SRF Limited

BSE:503806 株式レポート

時価総額：₹781.8b

SRF 過去の業績

過去 基準チェック /46

SRFの収益は年間平均-2.8%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間6.7% 7.5%割合で 増加しています。 SRFの自己資本利益率は13.1%であり、純利益率は11.6%です。

主要情報

-2.82%

収益成長率

-2.98%

EPS成長率

Chemicals 業界の成長17.68%
収益成長率7.54%
株主資本利益率13.07%
ネット・マージン11.63%
前回の決算情報31 Mar 2026

最近の業績更新

Recent updates

ナラティブの更新 • Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
ナラティブの更新 • Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
ナラティブの更新 • Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
ナラティブの更新 • Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
ナラティブの更新 • Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
ナラティブの更新 • Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
ナラティブの更新 • Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
ナラティブの更新 • Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
ナラティブの更新 • Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
ナラティブの更新 • Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
ナラティブの更新 • Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
ナラティブの更新 • Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
ナラティブの更新 • Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
ナラティブの更新 • Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
ナラティブの更新 • Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
新しいナラティブ • Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

収支内訳

SRF の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

BSE:503806 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
31 Mar 26157,86518,35211,4830
31 Dec 25154,84717,79211,5480
30 Sep 25152,63516,17611,3470
30 Jun 25150,47614,30911,1100
31 Mar 25146,93112,50810,8590
31 Dec 24139,49511,46910,5470
30 Sep 24135,11211,29310,3780
30 Jun 24132,64312,28610,1100
31 Mar 24131,38513,3579,7680
31 Dec 23133,46914,7609,4220
30 Sep 23137,63517,3349,0860
30 Jun 23143,13919,1368,7720
31 Mar 23148,70321,6238,5350
31 Dec 22146,41622,0558,4350
30 Sep 22145,17822,0028,4010
30 Jun 22136,29021,0168,2260
31 Mar 22124,33718,8898,1040
31 Dec 21114,91916,6477,5970
30 Sep 21102,92414,8347,1080
30 Jun 2195,54314,1676,6590
31 Mar 2184,00011,9836,3930
31 Dec 2076,50210,1106,0790
30 Sep 2073,54310,3225,8680
30 Jun 2069,9139,1745,6520
31 Mar 2072,0949,1595,5670
31 Dec 1978,8179,5116,0600
30 Sep 1978,4117,5925,8620
30 Jun 1971,2166,3314,9930
31 Mar 1970,9965,9164,9010
31 Dec 1872,3295,7475,3060
30 Sep 1866,6605,4025,1990
30 Jun 1860,3704,9174,7770
31 Mar 1855,8904,6175,0350
31 Dec 1753,0264,6704,9510
30 Sep 1750,3854,4424,8270
30 Jun 1748,9524,6424,4650
31 Mar 1748,2185,1504,5850
31 Dec 1645,8334,7874,4910
30 Sep 1645,4594,7094,3630
30 Jun 1645,9804,5374,0160
31 Mar 1645,9274,2994,0940
31 Dec 1545,3533,7465,7880
30 Sep 1545,5113,4535,7220
30 Jun 1545,7593,2355,7010

質の高い収益: 503806は 高品質の収益 を持っています。

利益率の向上: 503806の現在の純利益率 (11.6%)は、昨年(8.5%)よりも高くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 503806の収益は過去 5 年間で年間2.8%減少しました。

成長の加速: 503806の過去 1 年間の収益成長率 ( 46.7% ) は、5 年間の平均 ( 年間-2.8%を上回っています。

収益対業界: 503806の過去 1 年間の収益成長率 ( 46.7% ) はChemicals業界10.4%を上回りました。

株主資本利益率

高いROE: 503806の 自己資本利益率 ( 13.1% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/22 01:29
終値2026/05/22 00:00
収益2026/03/31
年間収益2026/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

SRF Limited 31 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。42

アナリスト機関
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital